NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Short Interest Update

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) saw a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 190,800 shares, a growth of 43.4% from the January 31st total of 133,100 shares. Based on an average daily volume of 250,900 shares, the days-to-cover ratio is currently 0.8 days. Approximately 0.7% of the company’s shares are short sold.

Hedge Funds Weigh In On NeuroOne Medical Technologies

Hedge funds have recently made changes to their positions in the stock. Jane Street Group LLC acquired a new position in NeuroOne Medical Technologies during the fourth quarter worth $33,000. Geode Capital Management LLC raised its holdings in shares of NeuroOne Medical Technologies by 9.8% in the 4th quarter. Geode Capital Management LLC now owns 311,659 shares of the company’s stock valued at $257,000 after buying an additional 27,804 shares during the period. Finally, XTX Topco Ltd acquired a new position in NeuroOne Medical Technologies during the 3rd quarter worth about $26,000. Hedge funds and other institutional investors own 16.07% of the company’s stock.

NeuroOne Medical Technologies Stock Performance

Shares of NeuroOne Medical Technologies stock traded down $0.05 during trading hours on Monday, hitting $1.07. The company’s stock had a trading volume of 226,863 shares, compared to its average volume of 259,891. The firm has a fifty day moving average of $1.05 and a 200-day moving average of $0.91. The stock has a market cap of $33.02 million, a price-to-earnings ratio of -4.12 and a beta of 0.48. NeuroOne Medical Technologies has a twelve month low of $0.55 and a twelve month high of $1.50.

NeuroOne Medical Technologies (NASDAQ:NMTC) last announced its earnings results on Wednesday, February 12th. The company reported $0.06 earnings per share for the quarter. NeuroOne Medical Technologies had a negative net margin of 82.17% and a negative return on equity of 270.70%.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.